Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Treatment of Adolescent Suicide Attempters (TASA)

ClinicalTrials.gov ID: NCT00080158

Public ClinicalTrials.gov record NCT00080158. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 3:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00080158
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
New York State Psychiatric Institute
Other
Enrollment
120 participants

Conditions and interventions

Interventions

  • fluoxetine Drug
  • sertraline Drug
  • citalopram Drug
  • escitalopram Drug
  • bupropion Drug
  • mirtazapine Drug
  • venlafaxine Drug
  • lithium Drug
  • Cognitive Behavioral Therapy Behavioral

Drug · Behavioral

Eligibility (public fields only)

Age range
12 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2004
Primary completion
Not listed
Completion
May 31, 2007
Last update posted
Jun 21, 2020

2004 – 2007

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Johns Hopkins University Baltimore Maryland 21287
New York University Child Study Center New York New York 10016
Columbia University at the New York State Psychiatric Institute New York New York 10032
Duke University Medical Center Durham North Carolina 27705
University of Pittsburgh - Western Psychiatric Institute and Clinic Pittsburgh Pennsylvania 15213
University of Texas, Southwestern Medical Center Dallas Texas 75235

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00080158, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00080158 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →